Podcast Episodes
Back to Search
First-Generation TRK Inhibitors: Clinical Evidence and Indications
Episode 90
In this episode, George D. Demetri, MD, and Alexander Drilon, MD, discuss key clinical data leading to FDA approvals and current indications for firs…
4 years, 8 months ago
PARP Inhibitors in Ovarian Cancer: Experts Discuss Patient Cases and the Current Paradigm
Episode 91
In this episode, Nicoletta Colombo, MD; Philipp Harter, MD, PhD; and Alexandra Leary, MD, PhD, discuss patient cases from a live webinar on the curr…
4 years, 8 months ago
Counseling Patients and Caregivers on Prophylaxis Therapy for Severe Hemophilia A
Episode 88
In this episode, listen to Guy A. Young, MD, as he counsels a teenage patient with severe hemophilia A and the patient’s mother on various available …
4 years, 8 months ago
Rationale for NTRK Testing in Patients With Cancer
Episode 89
In this episode, George D. Demetri, MD, and Alexander Drilon, MD, discuss the biologic rationale behind testing for NTRK fusions in patients with var…
4 years, 8 months ago
Expert Answers to HCP Questions on Androgen Deprivation Therapy for Prostate Cancer
Episode 87
In this episode, Daniel W. Lin, MD; Alicia K. Morgans, MD, MPH; and David F. Penson, MD, answer audience questions from a live CCO webinar focused on…
4 years, 8 months ago
Expert Insight on Important Clinical Trial Data From ESMO 2021 Informing Treatment for Endometrial and Ovarian Cancer
Episode 86
In this episode, Prof. Isabelle Ray-Coquard, MD, PhD, and Bernard Doger de Spéville, MD, PhD, provide expert insights on key new data from ESMO 2021 …
4 years, 9 months ago
Expert Insight on New Evidence Poised to Change the Treatment Landscape in Melanoma
Episode 85
In this podcast episode, Jeffrey S. Weber, MD, PhD; Allison Betof Warner, MD, PhD; and Hussein Tawbi, MD, PhD, discuss recent key data on adjuvant an…
4 years, 9 months ago
Expert Insight on Practice Changing From IGCS 2021 Informing Treatment for Endometrial, Ovarian, and Cervical Cancer
Episode 84
In this episode, Domenica Lorusso, MD, PhD, and Alexandra Leary, MD, PhD, provide expert insights on practice changing data from IGCS 2021 presented …
4 years, 9 months ago
Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address FAQs
Episode 83
In this episode, Paul G. Richardson, MD; Nina Shah, MD; and Peter M. Voorhees, MD, answer questions from a live webinar providing their thoughts on h…
4 years, 10 months ago
Expert Insights on Optimal Use of CDK4/6 Inhibitors for HR-Positive/HER2-Negative Breast Cancer
Episode 82
In this episode, Dr. Joyce O’Shaughnessy, MD, leads an engaging discussion with Matthew P. Goetz, MD, and Sara Hurvitz, MD, FACP, on leveraging CDK4/…
4 years, 10 months ago